DCF — LEXINGTON MEDICAL CENTER
Enterprise Value: $-118.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-118.6M
Enterprise Value
$-74.2M
PV of Cash Flows
$-44.3M
PV of Terminal Value
$-71.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.5B | $24.2M | 2.0% | $-38.2M | $-34.7M |
| Year 2 | $1.5B | $40.1M | 3.0% | $-24.7M | $-20.4M |
| Year 3 | $1.6B | $57.0M | 4.0% | $-13.7M | $-10.3M |
| Year 4 | $1.6B | $66.7M | 4.0% | $-8.1M | $-5.5M |
| Year 5 | $1.7B | $72.9M | 4.0% | $-5.2M | $-3.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-118.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.4B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.01141042717315386
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5